Vanberra Signal
Free trial

JSI Medical Systems

Curated by Signal

NGS analysis software provider

Life Sciences Technologyjsi-medisys.de

Overview

JSI Medical has developed bio-informatic software solutions covering a wide field of sequencing techniques, such as Capillary Sequencing, Affymetrix Chip Resequencing, Next Generation Sequencing, MLPA Analysis and HLA Sequencing-Based Typing. The product portfolio of the company includes Seq-Next, SeqNext HLA, Seq-Patient, MLPA, Seq HLA etc.

Key facts

Founded
1998
Headquarters
Ettenheim, Germany
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

7 products and services
Sign up to view

Contact

Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Reproline Medical

    Products portfolio for in-vitro fertility

    Life Sciences TechnologyRheinbach, Germany

  • Rexton

    Developer and manufacturer of hearing aids

    Life Sciences TechnologyErlangen, Germany

  • Sherlog

    Provider of platform for medical image analysis

    Life Sciences TechnologyHamburg, Germany

About JSI Medical Systems

What does JSI Medical Systems do?

JSI Medical has developed bio-informatic software solutions covering a wide field of sequencing techniques, such as Capillary Sequencing, Affymetrix Chip Resequencing, Next Generation Sequencing, MLPA Analysis and HLA Sequencing-Based Typing.

Where is JSI Medical Systems headquartered?

JSI Medical Systems is headquartered in Ettenheim, Germany.

When was JSI Medical Systems founded?

JSI Medical Systems was founded in 1998.

Which sector is JSI Medical Systems in?

JSI Medical Systems operates in Life Sciences Technology.

Who are JSI Medical Systems's competitors?

Companies similar to JSI Medical Systems include Reproline Medical, Rexton, and Sherlog.